A synergistic chlorhexidine/chitosan combination for improved antiplaque strategies

Journal of Periodontal Research

Volumn 40, Issue 5, 2005, Pages 373-377

  Decker, E M ^a,b   Von Ohle, C ^a   Weiger, R ^a   Wiech, I ^a   Brecx, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ZMK Klinik   (Germany)

Author keywords

Chitosan; Chlorhexidine; Streptococcus sanguinis; Synergistic effect

Indexed keywords

CHELATING AGENT; CHITOSAN; CHLORHEXIDINE; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL COUNT; BACTERIUM ADHERENCE; BIOFILM; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; ENAMEL; HUMAN; MICROBIOLOGY; PHYSIOLOGY; PILOT STUDY; SALIVA; SALIVATION; STREPTOCOCCUS SANGUINIS; TOOTH PLAQUE;

ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL ADHESION; BIOFILMS; CHELATING AGENTS; CHITOSAN; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; DENTAL ENAMEL; DENTAL PLAQUE; DRUG COMBINATIONS; DRUG SYNERGISM; HUMANS; PILOT PROJECTS; SALIVA; SALIVATION; STREPTOCOCCUS SANGUIS;

EID: 24344469984     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2005.00817.x     Document Type: Article

References (24)

1. Spijkervet FK, van Saene JJ, van Saene HK, Panders AK, Vermey A, Fidler V. Chlorhexidine inactivation by saliva. Oral Surg Oral Med Oral Pathol 1990;69:444-449.
2. Jenkins S, Addy M, Newcombe R. Comparison of two commercially available chlorhexidine mouthrinses. II. Effects on plaque reformation, gingivitis and tooth staining. Clin Prev Dent 1989;11:12-16.
3. Stabholz A, Kettering J, Aprecio R, Zimmerman G, Baker PJ, Wikesjo UM. Retention of antimicrobial activity by human root surfaces after in situ subgingival irrigation with tetracycline HCl or chlorhexidine. J Periodontol 1993;64:137-141.
4. Trüper HG, De Clari F. Taxonomic note: necessary correction of specific epithets formed as substantives (nouns) 'in apposition'. Int J Syst Bacteriol 1997;47:908-909.
5. Emilson CG. Potential efficacy of chlorhexidine against mutans streptococci and human dental caries. J Dent Res 1994;73:682-691.
6. Emilson CG. Susceptibility of various microorganisms to chlorhexidine. Scand J Dent Res 1977;85:255-265.
7. Chen Y-M, Chung Y-C, Wang L-W, Chen K-T, Li S-Y. Antibacterial properties of chitosan in waterborn pathogen. J Environ Sci Health 2002;A37:1379-1390.
8. Rabea EI, Badawy ME-T, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003;4:1457-1465.
9. Senel S, Ikinci G, Kas S, Yousefi-Rad A, Sargon MF, Hincal AA. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm 2000;193:197-203.
10. Needleman IG, Smales FC, Martin GP. An investigation of bioadhesion for periodontal and oral mucosal drug delivery. J Clin Periodontol 1979;24:394-400.
11. Lin DM, Kalachandra S, Valiyaparambil J, Offenbacher S. A polymeric device for delivery of anti-microbial and anti-fungal drugs in the oral environment: effect of temperature and medium on the rate of drug release. Dent Mater 2003;19:589-596.
12. Wilson M, Patel H, Fletcher J. Susceptibility of biofilms of Streptococcus sanguis to chlorhexidine gluconate and cetylpyridinium chloride. Oral Microbiol Immunol 1996;11:188-192.
13. Decker E-M, Weiger R, Wiech I, Heide P-E, Brecx M. Comparison of antiadhesive and antibacterial effects of antiseptics on Streptococcus sanguinis. Eur J Oral Sci 2003;111:144-148.
14. Decker E-M. The ability of direct fluorescence-based, two-colour assays to detect different physiological states of oral streptococci. Lett Appl Microbiol 2001;33:188-192.
15. Attin R, Tuna A, Brunner E, Noack MJ. Efficacy of differently concentrated chlorhexidine varnishes in decreasing Mutans streptococci and lactobacilli counts. Arch Oral Biol 2003;48:503-509.
16. Hildebrandt GH, Pape HR Jr, Syed SA, Gregory WA, Friedman M. Effect of slow-release chlorhexidine mouthguards on the levels of selected salivary bacteria. Caries Res 1992;26:268-274.
17. Tarsi R, Muzzarelli RAA, Guzmàn CA, Pruzzo C. Inhibition of Streptococcus mutans adsorption to hydroxyapatite by low molecular weight chitosans. J Dent Res 1997;76:665-672.
18. Chung Y-C, Su Y-P, Chen C-C et al. Relationship between antibacterial activity of chitosan and surface characteristics of cell wall. Acta Pharmacol Sin 2004;25:932-936.
19. Tarsi R, Corbin B, Pruzzo C, Muzzarelli RAA. Effect of low-molecular-weight chitosans on the adhesive properties of oral streptococci. Oral Microbiol Immunol 1998;13:217-224.
20. Ikinci G, Senel S, Akincibay H et al. Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. Int J Pharm 2002;235:121-127.
21. Liljemark WF, Bloomquist CG, Germaine GR. Effect of bacterial aggregation on the adherence of oral streptococci to hydroxyapatite. Infect Immun 1981;31:935-941.
22. Giunchedi P, Juliano C, Gavini E, Cossu M, Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur J Pharm Biopharm 2002;53:233-239.
23. Pittler MH, Abbot NC, Harkness EF, Ernst E. Randomised, double-blind trial of chitosan for body weight reduction. Eur J Clin Nutr 1999;53:379-381.
24. Arai K, Kinumaki T, Fujita T. Toxicity of chitosan. Bull Tokai Reg Fish Lab 1968;43:89-94.